Cargando…

Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma

We attempted to establish an ultrasound (US) imaging-diagnostic system for histopathological grades of differentiation of hepatocellular carcinoma (HCC). We conducted a retrospective study of histopathologically confirmed 200 HCCs, classified as early (45 lesions), well- (31 lesions), moderately (68...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feiqian, Numata, Kazushi, Nakano, Masayuki, Tanabe, Mikiko, Chuma, Makoto, Nihonmatsu, Hiromi, Nozaki, Akito, Ogushi, Katsuaki, Luo, Wen, Ruan, Litao, Okada, Masahiro, Otani, Masako, Inayama, Yoshiaki, Maeda, Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277955/ https://www.ncbi.nlm.nih.gov/pubmed/32438701 http://dx.doi.org/10.3390/diagnostics10050321

Ejemplares similares

Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection
por: Wang, Feiqian, et al.
Publicado: (2022)

Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report
por: Komiyama, Satoshi, et al.
Publicado: (2021)

Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
por: Wang, Feiqian, et al.
Publicado: (2022)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment
por: Fukuda, Hiroyuki, et al.
Publicado: (2018)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression
por: Kondo, Masaaki, et al.
Publicado: (2017)

Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
por: Tarao, Kazuo, et al.
Publicado: (2020)

Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
por: Okada, Masahiro, et al.
Publicado: (2022)

Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma
por: Tarao, Kazuo, et al.
Publicado: (2021)

Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study
por: Nozaki, Akito, et al.
Publicado: (2021)

Usefulness of 3D slicer for the planning and monitoring of hepatocellular carcinoma treatment using FUS
por: Doba, Nobutaka, et al.
Publicado: (2015)

Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma
por: Hao, Yoshiteru, et al.
Publicado: (2017)

Respiratory motion tracking system of hepatocellular carcinoma treatment using FUS
por: Fukuda, Hiroyuki, et al.
Publicado: (2015)

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
por: Chuma, Makoto, et al.
Publicado: (2020)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis
por: Tarao, Kazuo, et al.
Publicado: (2021)

TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial-to-mesenchymal transition via activation of AKT signaling regulated by miR-195-5p
por: Wang, Feiqian, et al.
Publicado: (2018)

Consistency of Trans-Abdominal and Water-Immersion Ultrasound Images of Diseased Intestinal Segments in Crohn’s Disease
por: Wang, Feiqian, et al.
Publicado: (2020)

High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas
por: Fukuda, Hiroyuki, et al.
Publicado: (2013)

Safety and Efﬁcacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis
por: Ogushi, Katsuaki, et al.
Publicado: (2020)

Intraductal Carcinoma of the Parotid Gland Presenting as Parapharyngeal Mass
por: Oki, Yamato, et al.
Publicado: (2020)

Fulminant Amebic Enteritis in the Perinatal Period
por: Azuma, Daisuke, et al.
Publicado: (2022)

Study on automatic detection and classification of breast nodule using deep convolutional neural network system
por: Wang, Feiqian, et al.
Publicado: (2020)

The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
por: Kawamura, Atsushi, et al.
Publicado: (2022)

Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography
por: Miwa, Haruo, et al.
Publicado: (2014)

Inflammatory bowel disease-specific findings are common morphological changes in the ileal pouch with ulcerative colitis
por: Toritani, Kenichiro, et al.
Publicado: (2022)

Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting
por: Fukushima, Taito, et al.
Publicado: (2021)

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
por: Fukushima, Taito, et al.
Publicado: (2023)

Ureteroscopy-Assisted Biopsy for a Retroperitoneal Tumor: A Case Report
por: Maeda, Yoko, et al.
Publicado: (2015)

Bronchopleural fistula following M. abscessus infection 11 years after lobectomy for lung cancer
por: Inayama, Mami, et al.
Publicado: (2013)

EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
por: He, Xiaoping, et al.
Publicado: (2022)

Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
por: Zhang, Ying, et al.
Publicado: (2022)

Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn’s disease
por: Sasaki, Tomohiko, et al.
Publicado: (2014)

Multiple Low-Grade Fibromyxoid Sarcoma on the Upper Arms with Atypical Histological Presentation
por: Furudate, Sadanori, et al.
Publicado: (2013)

Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2020)

Author Correction: Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_grlvb7lrm88v39od2171inv2o7